Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Iodine (131I) norcholesterol is a radioiodine-labeled cholesterol analogue that accumulates in areas where steroid hormones are produced. It is used in diagnostic procedures to image the adrenal cortex. The drug concentrates in steroid hormone synthesizing tissues, enabling scintigraphic localization and characterization of endocrine dysfunction in the adrenal cortex and ovary. When administered with dexamethasone suppression, it can help differentiate between adrenal adenomas and hyperplasia, particularly in cases of primary aldosteronism where other diagnostic methods like CT scans and adrenal venous sampling yield inconclusive results.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on iodine (131I) norcholesterol.